Gregory Huhn

6.7k total citations
56 papers, 1.7k citations indexed

About

Gregory Huhn is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Gregory Huhn has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 22 papers in Epidemiology and 19 papers in Virology. Recurrent topics in Gregory Huhn's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (14 papers) and Hepatitis C virus research (12 papers). Gregory Huhn is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (14 papers) and Hepatitis C virus research (12 papers). Gregory Huhn collaborates with scholars based in United States, United Kingdom and Germany. Gregory Huhn's co-authors include Inger K. Damon, Mary G. Reynolds, Krista L. Yorita, James J. Sejvar, Robert C. Holman, Whitni Davidson, Matthew J. Kuehnert, Mary Beth Graham, Anna Likos and Brian R. Wood and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Gregory Huhn

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Huhn United States 19 1.1k 978 843 453 151 56 1.7k
Charlotte Charpentier France 24 1.2k 1.1× 439 0.4× 250 0.3× 1.4k 3.0× 101 0.7× 117 1.9k
Winnie Dong Canada 25 1.5k 1.4× 413 0.4× 287 0.3× 1.6k 3.5× 109 0.7× 59 2.0k
Leigh Anne Eller United States 20 1.2k 1.1× 639 0.7× 472 0.6× 726 1.6× 38 0.3× 62 1.8k
Nicole Vidal France 26 1.4k 1.2× 443 0.5× 189 0.2× 1.4k 3.1× 55 0.4× 73 1.9k
Sharon Cassol United States 27 1.3k 1.2× 699 0.7× 213 0.3× 1.4k 3.2× 78 0.5× 48 2.2k
Monica M. Parker United States 21 351 0.3× 692 0.7× 235 0.3× 1.1k 2.5× 302 2.0× 53 1.7k
Steve Kaye United Kingdom 30 1.2k 1.1× 1.1k 1.1× 194 0.2× 1.3k 2.9× 278 1.8× 83 2.8k
David Yirrell United Kingdom 22 1.0k 0.9× 521 0.5× 191 0.2× 734 1.6× 51 0.3× 63 1.5k
Adeeba Kamarulzaman Malaysia 23 708 0.6× 980 1.0× 178 0.2× 1.3k 2.8× 100 0.7× 52 1.9k
S Cassol Canada 16 872 0.8× 428 0.4× 153 0.2× 913 2.0× 108 0.7× 27 1.4k

Countries citing papers authored by Gregory Huhn

Since Specialization
Citations

This map shows the geographic impact of Gregory Huhn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Huhn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Huhn more than expected).

Fields of papers citing papers by Gregory Huhn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Huhn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Huhn. The network helps show where Gregory Huhn may publish in the future.

Co-authorship network of co-authors of Gregory Huhn

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Huhn. A scholar is included among the top collaborators of Gregory Huhn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Huhn. Gregory Huhn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huhn, Gregory, et al.. (2023). 1599. Real-World Efficacy of Long-Acting Cabotegravir and Rilpivirine in an Urban HIV Clinic. Open Forum Infectious Diseases. 10(Supplement_2). 3 indexed citations
2.
Huhn, Gregory, Lin Zhang, Ajay Nirula, et al.. (2022). COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine. PLoS ONE. 17(9). e0273323–e0273323. 3 indexed citations
3.
Shawa, Imad, et al.. (2021). A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2. Infectious Diseases and Therapy. 10(4). 1933–1947. 28 indexed citations
4.
Dougan, Marcelle, Ajay Nirula, Robert Gottlieb, et al.. (2021). Bamlanivimab+etesevimab for treatment of COVID-19 in high-risk ambulatory patients. 29(1). 33–33. 6 indexed citations
5.
Zhang, Lin, Michael Dougan, Peter Chen, et al.. (2021). Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together. Frontiers in Immunology. 12. 790469–790469. 14 indexed citations
6.
Huhn, Gregory, Moti Ramgopal, Mamta K. Jain, et al.. (2020). HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens. PLoS ONE. 15(1). e0224875–e0224875. 5 indexed citations
7.
Jayaweera, Dushyantha, Keri N. Althoff, Joseph J. Eron, et al.. (2020). Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV. PLoS ONE. 15(2). e0228847–e0228847. 30 indexed citations
8.
Kotwal, Vikram, Yuchen Wang, Bashar M. Attar, et al.. (2020). A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease. Digestive Diseases and Sciences. 66(6). 2084–2091. 6 indexed citations
9.
Huhn, Gregory, Joseph J. Eron, Pierre‐Marie Girard, et al.. (2019). Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study. AIDS Research and Therapy. 16(1). 23–23. 6 indexed citations
10.
Ibrahim, Mustafa E., Kristina M. Brooks, José Castillo‐Mancilla, et al.. (2018). Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible Sensor. AIDS Research and Human Retroviruses. 34(10). 835–837. 14 indexed citations
11.
Hodowanec, Aimee, Weihua Gao, Jill Plants, et al.. (2015). A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection. BMC Infectious Diseases. 15(1). 190–190. 20 indexed citations
12.
Hodowanec, Aimee, et al.. (2013). Characterization of CD4+ T-Cell Immune Activation and Interleukin 10 Levels Among HIV, Hepatitis C Virus, and HIV/HCV-Coinfected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(3). 232–240. 18 indexed citations
13.
Vasoo, Shawn, et al.. (2011). Phaeomycotic cysts caused by Phoma species. Diagnostic Microbiology and Infectious Disease. 70(4). 531–533. 6 indexed citations
14.
Huhn, Gregory, Sheila Badri, Frank Tverdek, et al.. (2010). Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution. AIDS Research and Therapy. 7(1). 44–44. 16 indexed citations
15.
Huhn, Gregory, et al.. (2008). Factors Associated With Newly Diagnosed HIV Among Persons With Concomitant Sexually Transmitted Diseases. Sexually Transmitted Diseases. 35(8). 731–737. 18 indexed citations
16.
Reynolds, Mary G., Krista L. Yorita, Whitni Davidson, et al.. (2006). Clinical Manifestations of Human Monkeypox Influenced by Route of Infection. The Journal of Infectious Diseases. 194(6). 773–780. 319 indexed citations
17.
Huhn, Gregory, Krista L. Yorita, Mary Beth Graham, et al.. (2005). Clinical Characteristics of Human Monkeypox, and Risk Factors for Severe Disease. Clinical Infectious Diseases. 41(12). 1742–1751. 416 indexed citations
18.
Huhn, Gregory, et al.. (2005). Two Outbreaks of Occupationally Acquired Histoplasmosis: More than Workers at Risk. Environmental Health Perspectives. 113(5). 585–589. 34 indexed citations
19.
Huhn, Gregory, Jennifer L. Brown, William Perea, et al.. (2005). Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons—Liberia, 2004. Vaccine. 24(6). 730–737. 31 indexed citations
20.
Dialynas, Deno P., et al.. (1997). Characterization of a New Human Macrophage Cell Line 2MAC. Cellular Immunology. 177(2). 182–193. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotte Charpentier Breakdown of academic impact, for papers by Winnie Dong Breakdown of academic impact, for papers by Leigh Anne Eller Breakdown of academic impact, for papers by Nicole Vidal Breakdown of academic impact, for papers by Sharon Cassol Breakdown of academic impact, for papers by Monica M. Parker Breakdown of academic impact, for papers by Steve Kaye Breakdown of academic impact, for papers by David Yirrell Breakdown of academic impact, for papers by Adeeba Kamarulzaman Breakdown of academic impact, for papers by S Cassol
Rankless by CCL
2026